Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02310126 · ClinicalTrials.gov registry record · NA

Handling Comparison Between Two Contact Lens Types

A NA study of Presbyopia, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
195
Enrollment target
8
Study locations

NCT02310126 is a NA study of Presbyopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 195 participants, below the 265-participant average among 38 other Presbyopia trials with a reported enrollment target (26% lower). The trial reports 8 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02310126, a NA study of Presbyopia, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
195 participants
Enrollment target
8
Study locations

Study Summary

Subjects will evaluate each study lens in a random order. The lenses will be worn in both eyes for a short period.

Conditions Studied

Interventions

  • DEVICE etafilcon A (multi-focal)
  • DEVICE etafilcon A (sphere)

Study Locations (8)

Florida

  • Baymeadows Vision Center - Jacksonville
  • Eye Elements Eyecare - Jacksonville
  • Vistakon Research Clinic - Jacksonville
  • Golden Family Eyecare - Sarasota
  • Eye Associates of Winter Park - Winter Park

Tennessee

  • Optometry Group LLC - Memphis
  • Nashville Vision Associates - Nashville

Ohio

  • Central Ohio Eyecare - Columbus

Trial Details

FieldValue
Enrollment Target 195 participants
Start Date 2014-11-01
Est. Completion 2014-12-01
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT02310126

The ClinicalTrials.gov registry entry for NCT02310126 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 265-participant average among 38 other Presbyopia trials with a reported enrollment target (26% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which etafilcon A (multi-focal) is the first listed.

NCT02310126 reports 8 study locations spanning 3 distinct geographic areas - top geographies include Florida, Tennessee, Ohio.

Frequently Asked Questions

What is clinical trial NCT02310126 about?

NCT02310126 is a clinical study titled "Handling Comparison Between Two Contact Lens Types". Subjects will evaluate each study lens in a random order. The lenses will be worn in both eyes for a short period.

What is the current status of trial NCT02310126?

This trial is currently completed. It is a NA study. The enrollment target is 195 participants. The study started on 2014-11-01. Estimated completion is 2014-12-01.

What conditions does trial NCT02310126 study?

This clinical trial studies the following conditions: Presbyopia.

What interventions are being tested in trial NCT02310126?

The interventions under investigation include: etafilcon A (multi-focal) (DEVICE), etafilcon A (sphere) (DEVICE).

Who is sponsoring clinical trial NCT02310126?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02310126 being conducted?

This trial has 8 study locations across Florida, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Presbyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.